Pinatuzumab 是一种 CD22 单克隆抗体。Pinatuzumab 靶向细胞表面抗原 CD22。Pinatuzumab 可用于合成抗体药物偶联物 (ADC)，以研究包括非霍奇金淋巴瘤 (NHL) 在内的多种疾病。
| 生物活性 | Pinatuzumab is aCD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL)[1][2]. |
| Clinical Trial | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com